Is there any change in the latest medical insurance reimbursement policy for Alpelisib in 2025?

As of2025, Alpelisib (Alpelisib) has not yet received official marketing approval in mainland China, and therefore is not included in the national medical insurance directory. Because it is not on the market, patients cannot get prescriptions issued through regular hospitals, nor can they enjoy medical insurance reimbursement policies. Currently, there is no medical insurance in China to support the clinical application of this drug. Even if some patients have drug needs, they can only purchase drugs at their own expense through overseas channels.

Apelis is currently mainly obtained through overseas channels. According to market knowledge, the Indian version of the original drug is priced at approximately more than 3,000 yuan per box, making it a relatively high-priced targeted drug. The generic version launched by Laos pharmaceutical factory is relatively cheap, about more than 1,000 yuan per box. Although the price difference is large, the active ingredients of the two are basically the same, but patients still need to carefully consider their own conditions and economic conditions when choosing.

Although Apelis has not yet been included in medical insurance, judging from the country's accelerated pace of new drug approval and medical insurance negotiations in recent years, there is a certain possibility of being included in medical insurance in the future. Especially when the drug is officially launched in China, if there is great clinical demand and the price is adjusted through negotiation, it may be included in the medical insurance list. However, there has been no official announcement of relevant news or approval progress in the short term, and patients still need to wait patiently.

For patients who are in urgent need of medication, it is recommended to obtain overseas versions through formal channels to ensure drug quality and safety. At the same time, you should maintain communication with your attending doctor, evaluate the risks and benefits of medication, and try to avoid changing or adjusting the dosage on your own. In addition, some hospitals are participating in overseas drug clinical projects. Those in need of drugs can also pay attention to the dynamics of relevant pilot hospitals and seek professional guidance and assistance.